News
PFE
51.14
+0.96%
0.48
Taiwan to receive first doses of Novavax COVID vaccine this week
Taiwan to receive first doses of Novavax COVID vaccine this week
Reuters · 9h ago
These companies' values soared during the pandemic. Here's how they are faring in 2022's turbulent market.
The pandemic-era bull market drove the values of many companies to lofty heights. Here's how those star performers are faring during a much more turbulent 2022.
American City Business Journals · 10h ago
Pfizer, Moderna, Novavax: FDA Experts Vote 19-2 To Include Omicron Shot In Covid Boosters
A split FDA panel voted Tuesday to recommend including an omicron component in updated Covid boosters this fall.
Investor's Business Daily · 18h ago
Covid Boosters Should Get Omicron-Targeted Update: FDA Panel
Bloomberg · 18h ago
Pfizer, Moderna to be ready with BA.1-specific COVID boosters
Pfizer Inc and Moderna Inc said on Tuesday they will be ready with COVID-19 vaccines designed to combat the BA.1 Omicron variant that was dominant last winter earlier than those designed to target currently dominant subvariants. Moderna said it would be r...
Reuters · 20h ago
Is Pfizer Stock A Buy As FDA Considers Its Omicron-Specific Shot?
Is Pfizer stock a buy as the FDA considers its omicron shot narrowly after authorizing its Covid vaccine for babies? Is PFE stock a buy?
Investor's Business Daily · 21h ago
J&J does not plan to update its COVID-19 vaccine
Johnson & Johnson does not plan to update its COVID-19 vaccine, though other vaccine makers like Moderna Inc. , BioNTech SE and Pfizer Inc. , and Novavax Inc. are already working on new versions that aim to better protection against the currently circulati...
marketwatch.com · 22h ago
FDA targets updated COVID-19 vaccines for adults by October
A top vaccine official at the FDA said on Tuesday that the agency would decide whether to change the composition of the current generation of COVID-19 shots by early July
Seekingalpha · 23h ago
Newer, more contagious Omicron subvariants become dominant in U.S.
Latest estimates from the Centers for Disease Control and Prevention (CDC) indicated on Tuesday that two highly transmissible sub-variants of Omicron accounted for more than 50% of all coronavirus cases.
Seekingalpha · 1d ago
Roivant axes gene therapy, dermatology and excessive sweating candidates from development
Roivant Sciences (NASDAQ:ROIV) is ending development of its top lentiviral gene therapy, ARU0-1801, for sickle cell disease and β-thalassemia, due to future development costs and current market environment. Also, as part
Seekingalpha · 1d ago
UPDATE 3-U.S. FDA advisers recommend change to COVID vaccine composition for fall
Advisers to the U.S. Food and Drug Administration on Tuesday recommended a change in the design of COVID-19 booster shots this fall in order to combat more recently circulating variants of the coronavirus. The FDA's Vaccines and Related Biological Product...
Reuters · 1d ago
Sector Update: Health Care
MT Newswires · 1d ago
Company News for Jun 28, 2022
Companies in The News Are: BNTX,PFE,WBA,HOOD,SAVE,ULCC,JBLU
Zacks · 1d ago
Roivant, Pfizer Unveil Latest Spinout Focused On Autoimmune Diseases
Benzinga · 1d ago
US Government Offers $75M Support For Lipid Systems Expansion Used In mRNA COVID-19 Vaccines
Benzinga · 1d ago
BRIEF-Roivant And Pfizer Unveil Priovant Therapeutics And Ongoing Registrational Studies For Oral Brepocitinib In Dermatomyositis And Lupus
BRIEF-Roivant And Pfizer Unveil Priovant Therapeutics And Ongoing Registrational Studies For Oral Brepocitinib In Dermatomyositis And Lupus
Reuters · 1d ago
Roivant Sciences teams up with Pfizer to launch Priovant
U.K.-based pharmaceutical company Roivant Sciences (NASDAQ:ROIV) and Pfizer (PFE) announced on Tuesday the launch of Priovant Therapeutics, a clinical-stage biotech focused on autoimmune diseases. In September 2021, Pfizer (PFE) licensed
Seekingalpha · 1d ago
Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges
Shares of Roivant Sciences Ltd. shot up 10.0% in premarket trading Tuesday, after the biopharmaceutical company and drug giant Pfizer Inc. unveiled Priovant Therapeutics, a biotechnology company focused on developing novel therapies for autoimmune diseases...
marketwatch.com · 1d ago
Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five placebo-controlled studies completed to date, oral brepocitinib generated statistically significant and clinically meaningful resultsPriovant is developing b...
GlobeNewswire · 1d ago
States could ban abortion pill for Medicaid enrollees, experts say
States could sidestep FDA-approved abortion pills after the Supreme Court overturned Roe v. Wade. But it remains to be seen if the federal government can enforce access.
Yahoo Finance · 2d ago
More
Webull provides a variety of real-time PFE stock news. You can receive the latest news about Pfizer through multiple platforms. This information may help you make smarter investment decisions.
About PFE
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.